Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase
Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as...
Gespeichert in:
| Veröffentlicht in: | The FASEB journal Jg. 22; H. 12; S. 4209 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.12.2008
|
| Schlagworte: | |
| ISSN: | 1530-6860, 1530-6860 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as its peptide inhibitors exhibit memory-enhancing effects in both normal and memory-impaired rodents. Using a homology model of the catalytic domain of IRAP and virtual screening, we have identified a class of nonpeptide, small-molecule inhibitors of IRAP. Structure-based computational development of an initial "hit" resulted in the identification of two divergent families of compounds. Subsequent medicinal chemistry performed on the highest affinity compound produced inhibitors with nanomolar affinities (K(i) 20-700 nM) for IRAP. In vivo efficacy of one of these inhibitors was demonstrated in rats with an acute dose (1 nmol in 1 microl) administered into the lateral ventricles, improving performance in both spatial working and recognition memory paradigms. We have identified a family of specific IRAP inhibitors that is biologically active which will be useful both in understanding the physiological role of IRAP and potentially in the development of clinically useful cognitive enhancers. Notably, this study also provides unequivocal proof of principal that inhibition of IRAP results in memory enhancement. |
|---|---|
| AbstractList | Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as its peptide inhibitors exhibit memory-enhancing effects in both normal and memory-impaired rodents. Using a homology model of the catalytic domain of IRAP and virtual screening, we have identified a class of nonpeptide, small-molecule inhibitors of IRAP. Structure-based computational development of an initial "hit" resulted in the identification of two divergent families of compounds. Subsequent medicinal chemistry performed on the highest affinity compound produced inhibitors with nanomolar affinities (K(i) 20-700 nM) for IRAP. In vivo efficacy of one of these inhibitors was demonstrated in rats with an acute dose (1 nmol in 1 microl) administered into the lateral ventricles, improving performance in both spatial working and recognition memory paradigms. We have identified a family of specific IRAP inhibitors that is biologically active which will be useful both in understanding the physiological role of IRAP and potentially in the development of clinically useful cognitive enhancers. Notably, this study also provides unequivocal proof of principal that inhibition of IRAP results in memory enhancement. Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as its peptide inhibitors exhibit memory-enhancing effects in both normal and memory-impaired rodents. Using a homology model of the catalytic domain of IRAP and virtual screening, we have identified a class of nonpeptide, small-molecule inhibitors of IRAP. Structure-based computational development of an initial "hit" resulted in the identification of two divergent families of compounds. Subsequent medicinal chemistry performed on the highest affinity compound produced inhibitors with nanomolar affinities (K(i) 20-700 nM) for IRAP. In vivo efficacy of one of these inhibitors was demonstrated in rats with an acute dose (1 nmol in 1 microl) administered into the lateral ventricles, improving performance in both spatial working and recognition memory paradigms. We have identified a family of specific IRAP inhibitors that is biologically active which will be useful both in understanding the physiological role of IRAP and potentially in the development of clinically useful cognitive enhancers. Notably, this study also provides unequivocal proof of principal that inhibition of IRAP results in memory enhancement.Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as its peptide inhibitors exhibit memory-enhancing effects in both normal and memory-impaired rodents. Using a homology model of the catalytic domain of IRAP and virtual screening, we have identified a class of nonpeptide, small-molecule inhibitors of IRAP. Structure-based computational development of an initial "hit" resulted in the identification of two divergent families of compounds. Subsequent medicinal chemistry performed on the highest affinity compound produced inhibitors with nanomolar affinities (K(i) 20-700 nM) for IRAP. In vivo efficacy of one of these inhibitors was demonstrated in rats with an acute dose (1 nmol in 1 microl) administered into the lateral ventricles, improving performance in both spatial working and recognition memory paradigms. We have identified a family of specific IRAP inhibitors that is biologically active which will be useful both in understanding the physiological role of IRAP and potentially in the development of clinically useful cognitive enhancers. Notably, this study also provides unequivocal proof of principal that inhibition of IRAP results in memory enhancement. |
| Author | Fernando, Ruani N De Bundel, Dimitri Ng, Hooi Ling Yeatman, Holly R Mendelsohn, Frederick A O Parker, Michael W Morton, Craig J Albiston, Anthony L Chai, Siew Yeen Ye, Siying Pham, Vi Ascher, David B |
| Author_xml | – sequence: 1 givenname: Anthony L surname: Albiston fullname: Albiston, Anthony L organization: Howard Florey Institute, University of Melbourne, Parkville, VIC 3010, Australia – sequence: 2 givenname: Craig J surname: Morton fullname: Morton, Craig J – sequence: 3 givenname: Hooi Ling surname: Ng fullname: Ng, Hooi Ling – sequence: 4 givenname: Vi surname: Pham fullname: Pham, Vi – sequence: 5 givenname: Holly R surname: Yeatman fullname: Yeatman, Holly R – sequence: 6 givenname: Siying surname: Ye fullname: Ye, Siying – sequence: 7 givenname: Ruani N surname: Fernando fullname: Fernando, Ruani N – sequence: 8 givenname: Dimitri surname: De Bundel fullname: De Bundel, Dimitri – sequence: 9 givenname: David B surname: Ascher fullname: Ascher, David B – sequence: 10 givenname: Frederick A O surname: Mendelsohn fullname: Mendelsohn, Frederick A O – sequence: 11 givenname: Michael W surname: Parker fullname: Parker, Michael W – sequence: 12 givenname: Siew Yeen surname: Chai fullname: Chai, Siew Yeen |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18716029$$D View this record in MEDLINE/PubMed |
| BookMark | eNpN0LtPwzAQBnALFdEHbMzIE1uKncSOPaKKl1SJBebIj0t7VeKUOKGCv55IbSWmO51-3w3fnExCG4CQW86WnGn5UO2WTCWcp2laXJAZFxlLpJJs8m-fknmMO8YYZ1xekSlXBZcs1TNyePMQeqzQmR7bQE3w1G1NZ1wPHf4ej21FDQ1woK7dBOzxGyiErQkOOmpNBE9HhGGLFs8eQxxqDEkHm6E2_UhMg6Hdw75HP0auyWVl6gg3p7kgn89PH6vXZP3-8rZ6XCcu16pIMq9Sb52QLBfCy4xJAUpxLbUspGAu55XXosgzK6wSUmovtM-FyY21wApIF-T--HfftV8DxL5sMDqoaxOgHWIptcrHluQI705wsA34ct9hY7qf8lxV-gcQ223g |
| CitedBy_id | crossref_primary_10_3389_fphar_2020_590855 crossref_primary_10_3390_ijms252212016 crossref_primary_10_1007_s00115_009_2801_6 crossref_primary_10_1021_jm100793t crossref_primary_10_1111_jnc_14880 crossref_primary_10_1016_j_pneurobio_2011_07_001 crossref_primary_10_1038_srep29575 crossref_primary_10_12688_f1000research_160416_1 crossref_primary_10_12688_f1000research_160416_2 crossref_primary_10_3390_ijms25074084 crossref_primary_10_1007_s00424_012_1102_2 crossref_primary_10_1111_j_1476_5381_2011_01402_x crossref_primary_10_1002_med_21323 crossref_primary_10_1084_jem_20160534 crossref_primary_10_1124_pr_114_010454 crossref_primary_10_1021_acs_jcim_5b00359 crossref_primary_10_1016_j_neulet_2016_06_034 crossref_primary_10_1515_enr_2016_0025 crossref_primary_10_1016_j_jmb_2024_168449 crossref_primary_10_1021_jm200036n crossref_primary_10_3233_JAD_171119 crossref_primary_10_1016_j_humimm_2018_11_002 crossref_primary_10_1016_j_cbpa_2014_08_007 crossref_primary_10_1002_open_201402027 crossref_primary_10_3390_ijms23094961 crossref_primary_10_1093_nar_gkw390 crossref_primary_10_3389_fphar_2020_585838 crossref_primary_10_1111_j_1471_4159_2009_06547_x crossref_primary_10_1016_j_jaci_2023_01_014 crossref_primary_10_1073_pnas_1309781110 crossref_primary_10_1016_j_jinorgbio_2012_02_015 crossref_primary_10_1155_2012_789671 crossref_primary_10_1124_mol_115_102533 crossref_primary_10_1042_BST20160422 crossref_primary_10_1016_j_ejmech_2019_04_027 crossref_primary_10_1016_j_bbagen_2016_09_020 crossref_primary_10_1093_jb_mvab009 crossref_primary_10_1016_j_pneurobio_2014_11_004 crossref_primary_10_1111_j_2042_7158_2010_01247_x crossref_primary_10_1007_s00706_016_1733_7 crossref_primary_10_1089_adt_2016_708 crossref_primary_10_1002_pro_2604 crossref_primary_10_1016_j_pneurobio_2014_10_001 crossref_primary_10_1002_jcc_21307 crossref_primary_10_1002_med_21449 crossref_primary_10_1016_j_peptides_2009_07_019 crossref_primary_10_1038_gene_2014_46 crossref_primary_10_1089_neu_2011_1824 crossref_primary_10_3390_ph14060584 crossref_primary_10_3389_fimmu_2024_1466692 crossref_primary_10_1002_open_201900344 crossref_primary_10_3389_fmolb_2021_625274 crossref_primary_10_3390_ijms25052516 crossref_primary_10_3389_fcell_2020_585237 crossref_primary_10_1002_pro_5151 crossref_primary_10_1016_j_nlm_2009_07_011 crossref_primary_10_1016_j_yhbeh_2011_12_014 crossref_primary_10_1016_j_expneurol_2019_113076 crossref_primary_10_1038_nrendo_2015_6 crossref_primary_10_1002_ejoc_201402003 crossref_primary_10_1039_D5MD00438A crossref_primary_10_1055_a_2562_7204 crossref_primary_10_1080_17460441_2017_1322579 crossref_primary_10_1016_j_ejphar_2012_02_048 crossref_primary_10_1016_j_nlm_2016_09_017 crossref_primary_10_1124_pharmrev_120_000281 crossref_primary_10_1038_srep19848 crossref_primary_10_1038_s41598_023_46072_5 crossref_primary_10_1124_mol_110_065458 crossref_primary_10_1111_febs_14009 crossref_primary_10_3233_JAD_161265 crossref_primary_10_1016_j_mce_2008_11_015 crossref_primary_10_1016_j_jocn_2017_08_055 crossref_primary_10_3389_fphar_2020_585930 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1096/fj.08-112227 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1530-6860 |
| ExternalDocumentID | 18716029 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -~X .55 0R~ 0VX 123 18M 1OB 1OC 29H 2WC 33P 34G 39C 3O- 4.4 53G 5GY 5RE 85S AAHHS AAHQN AAMNL AANLZ AAYCA ABCUV ABDNZ ABEFU ABJNI ABOCM ACCFJ ACCZN ACGFS ACIWK ACNCT ACPOU ACPRK ACXQS ACYGS ADKYN ADZMN AEEZP AEIGN AENEX AEQDE AEUYR AFFNX AFFPM AFRAH AFWVQ AGCDD AHBTC AI. AITYG AIURR AIWBW AIZAD AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB BFHJK BIYOS C1A CGR CS3 CUY CVF DCZOG DU5 D~5 E3Z EBS ECM EIF EJD F5P F9R FRP H13 HGLYW HZ~ H~9 J5H L7B LATKE LEEKS MEWTI MVM NEJ NPM O9- OHT OVD Q-A RHF RHI RJQFR ROL SAMSI SJN SUPJJ TEORI TFA TR2 TWZ U18 VH1 VXZ W8F WH7 WHG WOQ WXSBR X7M XJT XOL XSW Y6R YBU YCJ YHG YKV YNH YSK Z0Y Z5M ZCA ZE2 ZGI ZXP ~KM 7X8 AAMMB ADXHL AEFGJ AEYWJ AGXDD AGYGG AIDQK AIDYY |
| ID | FETCH-LOGICAL-c4987-3d82dbc560455d63065e88196967650c41fd95743b5b85669d59d45a4abbe07e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 98 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000261254800020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1530-6860 |
| IngestDate | Sun Nov 09 12:38:50 EST 2025 Wed Feb 19 01:52:05 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4987-3d82dbc560455d63065e88196967650c41fd95743b5b85669d59d45a4abbe07e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 18716029 |
| PQID | 69845306 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_69845306 pubmed_primary_18716029 |
| PublicationCentury | 2000 |
| PublicationDate | December 2008 |
| PublicationDateYYYYMMDD | 2008-12-01 |
| PublicationDate_xml | – month: 12 year: 2008 text: December 2008 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The FASEB journal |
| PublicationTitleAlternate | FASEB J |
| PublicationYear | 2008 |
| SSID | ssj0001016 |
| Score | 2.2803319 |
| Snippet | Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 4209 |
| SubjectTerms | Animals Biological Assay Catalytic Domain Cystinyl Aminopeptidase - antagonists & inhibitors Drug Design Enzyme Inhibitors - pharmacology Male Memory - drug effects Models, Molecular Nootropic Agents - pharmacology Rats Rats, Sprague-Dawley Recognition (Psychology) - drug effects |
| Title | Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/18716029 https://www.proquest.com/docview/69845306 |
| Volume | 22 |
| WOSCitedRecordID | wos000261254800020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED4VChIL70d5emANJKnT2BISQoiKhaoDSN0qP9Ug4ZSWh_j3nOOkTIiBJdNZspzz-Tv7u_sAzqnArEdxixspjiMqlI6YFf4azmbKxFSkXFRiE_lgwEYjPmzBVVML42mVTUysArUulb8jv-xxRjPEt9fT18hrRvm31VpAYwnaXQ9k0Jvz0U-vcJ-Xhm6pmCCxXlzT3hGzX9rnC9_VNPGFoL9Dy-qI6W_8b3KbsF5DS3ITfGELWsZtw2oQm_zagc9Qk2vrSzoinCZq0a45VGOS0hJBEGmTBa2IGDfxnjEj_sDTBI0KNylk0djXbPZoFlTt0US8FK6cerqMxiG78NS_e7y9j2rZhUhR7kOOZqmWCqEQzTLd89LyhrGqjU6OeE7RxGqeIfKQmWSIBrnOuKaZoEJKE-cm3YNlVzpzAMR0JSaMJpeMJxSHCMR33GDYMInFzJR14KxZzzG6tX-rEM6U7_Nxs6Id2A-_ZDwN3TfGiU_x4pQf_jn2CNYqdkdFPjmGtsUNbU5gRX28FfPZaeUt-B0MH74Bl5jK_A |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+and+characterization+of+a+new+cognitive+enhancer+based+on+inhibition+of+insulin-regulated+aminopeptidase&rft.jtitle=The+FASEB+journal&rft.au=Albiston%2C+Anthony+L&rft.au=Morton%2C+Craig+J&rft.au=Ng%2C+Hooi+Ling&rft.au=Pham%2C+Vi&rft.date=2008-12-01&rft.eissn=1530-6860&rft.volume=22&rft.issue=12&rft.spage=4209&rft_id=info:doi/10.1096%2Ffj.08-112227&rft_id=info%3Apmid%2F18716029&rft_id=info%3Apmid%2F18716029&rft.externalDocID=18716029 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-6860&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-6860&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-6860&client=summon |